Skip to main content
559 Results
 
TB support in Swaziland
Eswatini

MSF hands over its Manzini project, while continuing activities in Shiselweni

As a mark of the project's success and the great gains made in the fight against HIV/AIDS and TB in Swaziland, MSF is handing over its Manzini project to the Ministry of Health at the end of June 2018. Statement - 25 Jun 2018
 
msf-placeholder
Tuberculosis

Pharmacokinetics of efavirenz in patients on antituberculosis treatment in high HIV and tuberculosis burden countries: a systematic review

Efavirenz (EFV) and Rifampicin-Isoniazid (RH) are cornerstone drugs in HIV-tuberculosis (TB) co-infection treatment but with complex drug interactions, efficacy and safety challenges. We reviewed recent data on EFV and RH interaction in TB/HIV high-burden countries. British Journal of Clinical Pharmacology - 6 Apr 2018
 
TB programs in Gulf Province and Port Moresby
Papua New Guinea

Bringing TB treatment closer to home

An estimated 30,000 new cases in 2016, expanding and improving TB care in PNG is an uphill battle. Project Update - 23 Mar 2018
 
Insein clinic, for treatment for HIV, TB, and Hepatitis C in Yangon. By Alessandro Penso, Feb 2018.
Tuberculosis

“An obvious, urgent focus for MSF”

Dr. Francis Varaine, leader of the MSF working group on Tuberculosis, explains MSF’s priorities over the next 10 years. Voices from the Field - 22 Mar 2018
 
MSF activities and daily life of the refugees in Tasnimarkhola camp.
International Women's Day

Caring for displaced women

For International Women’s Day 2018, against the backdrop of record levels of displacement, MSF is highlighting how health needs are exacerbated for women and girls on the move. Press Release - 6 Mar 2018
 
MSF HIV Programe in Bangui, Central African Republic
HIV/AIDS

Delivering differently to reach people living with HIV in West and Central Africa

This week, researchers, policy makers, clinicians and activists involved in the HIV response will attend ICASA 2017, in Abidjan, Côte d'Ivoire. Statement - 4 Dec 2017
 
HIV Clinics in Kinshasa
Democratic Republic of Congo

Left behind by the HIV response - Kinshasa

The Left behind by the HIV response report presents MSF’s clinical experience and epidemiological data from treating advanced HIV at CHK and other supported health facilities, along with recommendations for minimum diagnostic and therapeutic packages for advanced HIV at primary, referral and hospital levels, and costings for hospitalisation. The report calls for the funding and implementation of a referral system and free outpatient care and hospitalisation for advanced HIV in Kinshasa. The report also draws on the available literature and includes testimonies from patients who received hospital care in MSF’s Kinshasa HIV project and healthcare professionals specialized in the treatment of advanced HIV.

MSF Access campaign - 1 Dec 2017
 
Mykolaiv Project
Ukraine

People co-infected with HIV to receive hepatitis C treatment in Mykolaiv region

MSF has begun treatment for hepatitis C with people who are co-infected with hepatitis C and HIV in Mykolaiv region. Press Release - 1 Dec 2017
 
Chiradzulu: HIV care for adolescents
HIV/AIDS

MSF at ICASA 2017

MSF currently supports over 230,000 people living with HIV in 19 countries throughout Africa, Asia and Eastern Europe. Event - 1 Dec 2017
Cholera intervention in South Kivu
Médecins Sans Frontières (MSF)

Independent medical humanitarian assistance

We provide medical assistance to people affected by conflict, epidemics, disasters, or exclusion from healthcare. Our teams are made up of tens of thousands of health professionals, logistic and administrative staff - most of them hired locally. Our actions are guided by medical ethics and the principles of independence and impartiality. We are a non-profit, self-governed, member-based organisation.

Learn more